What is the appropriate workup for suspected disseminated intravascular coagulation (DIC)?

DIC Workup

The appropriate workup for suspected DIC requires a combination of platelet count, PT, fibrinogen, and D-dimer, with serial monitoring to detect dynamic changes, recognizing that no single test can establish or exclude the diagnosis. 1, 2

Core Laboratory Panel

The essential DIC workup consists of four key tests that should be obtained simultaneously 1, 3:

• Complete blood count with platelet count – Thrombocytopenia is typically present, though a "normal" platelet count may still indicate DIC if it represents a ≥30% decline from a previously elevated baseline 1, 3
• Prothrombin time (PT) – May be prolonged, but can remain normal in subclinical or early cancer-associated DIC 1
• Fibrinogen level – Decreased levels suggest consumption, though early DIC may show only moderate reductions 1
• D-dimer or fibrin degradation products (FDP) – Elevated levels reflect both coagulation activation and fibrinolysis; a normal D-dimer effectively rules out DIC 2, 4

Critical Diagnostic Considerations

Serial Monitoring is Essential

Single laboratory measurements are insufficient; repeat testing is mandatory to capture the dynamic nature of DIC. 1, 4

• In acute, severe DIC: obtain labs every 6 hours to daily 5
• In stable DIC: repeat daily 5
• In chronic, well-controlled cases: monthly monitoring may suffice 5

Pitfalls in Laboratory Interpretation

A 30% or greater drop in platelet count should be considered diagnostic of subclinical DIC even when the absolute count remains within the normal laboratory range. 1, 5, 3 This is particularly critical in malignancy-associated DIC, where an initial thrombocytosis may decline to "normal" levels—a change that is often incorrectly dismissed as unimportant but may be the only laboratory sign of ongoing DIC 1.

Normal PT and aPTT do not exclude DIC. Coagulation times may remain normal in approximately 50% of DIC cases, especially in subclinical or early cancer-associated forms where coagulation factor depletion is only moderate 1, 3.

Diagnostic Scoring Systems

ISTH Overt-DIC Score (for established DIC)

Apply this scoring system when DIC is clinically suspected 1:

• Platelet count: <50 × 10⁹/L = 2 points; 50–100 × 10⁹/L = 1 point
• D-dimer/FDP: Strong increase = 3 points; moderate increase = 2 points
• PT prolongation: ≥6 seconds = 2 points; 3–6 seconds = 1 point
• Fibrinogen: <1.0 g/L = 1 point

Score ≥5 indicates overt DIC 1

Sepsis-Induced Coagulopathy (SIC) Score (for early-phase DIC in sepsis)

Use this for earlier detection in septic patients 1:

• Platelet count: <100 × 10⁹/L = 2 points; 100–150 × 10⁹/L = 1 point
• PT ratio: >1.4 = 2 points; 1.2–1.4 = 1 point
• SOFA score: ≥2 = 2 points; 1 = 1 point

Score ≥4 indicates SIC 1

Additional Laboratory Tests

Optional but Informative

• Peripheral blood smear – May reveal schistocytes indicating microangiopathic hemolytic anemia, supporting the diagnosis 1
• Antithrombin activity – Decreased levels reflect consumption and correlate with severity, though not routinely incorporated into diagnostic algorithms 1, 2
• von Willebrand factor – Elevated levels may reflect endothelial injury, though not widely available 1

Tests That Are Not Useful

• aPTT alone – Has limited diagnostic efficiency and may be normal in DIC 1, 2
• Individual coagulation factor levels – Not necessary for diagnosis and do not guide management 2

Clinical Context Integration

Laboratory results must be interpreted alongside clinical presentation and identification of an underlying trigger. 1, 6, 7 The workup should simultaneously investigate potential causes:

• Sepsis – Blood cultures, procalcitonin, source identification 1
• Malignancy – Particularly adenocarcinoma, pancreatic cancer, acute promyelocytic leukemia, metastatic prostate cancer 1
• Trauma – Recent injury, surgery 1
• Obstetric complications – Placental abruption, amniotic fluid embolism, eclampsia 1

Phenotype Recognition

Once DIC is diagnosed, classify the clinical phenotype to guide management 1, 8:

• Procoagulant DIC – Predominant thrombosis (arterial ischemia, venous thromboembolism); common in pancreatic cancer and adenocarcinoma 1, 8
• Hyperfibrinolytic DIC – Predominant bleeding (mucosal hemorrhage, widespread bruising); typical of acute promyelocytic leukemia and metastatic prostate cancer 1, 8
• Subclinical DIC – Laboratory abnormalities without overt clinical symptoms; may progress to overt DIC if untreated 1, 8

Common Pitfalls to Avoid

• Do not wait for all laboratory tests to be abnormal – DIC can be present with selective abnormalities, particularly in early phases 1
• Do not dismiss a declining platelet trend – A relative decrease is more important than the absolute value 1, 3
• Do not rely on a single set of labs – Serial measurements are essential to capture the evolving coagulopathy 1, 4
• Do not order tests in isolation from clinical context – DIC diagnosis requires integration of laboratory findings with clinical presentation and underlying disease 1, 6, 7